Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cresco Labs (CRLBF) Operating Expenses (2020 - 2026)

Cresco Labs filings provide 7 years of Operating Expenses readings, the most recent being $64.3 million for Q1 2026.

  • On a quarterly basis, Operating Expenses fell 1.18% to $64.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $351.8 million, a 35.74% increase, with the full-year FY2025 number at $352.6 million, up 37.09% from a year prior.
  • Operating Expenses hit $64.3 million in Q1 2026 for Cresco Labs, down from $158.9 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $231.2 million in Q4 2022 to a low of $61.5 million in Q3 2025.
  • Median Operating Expenses over the past 5 years was $69.0 million (2023), compared with a mean of $95.0 million.
  • Biggest five-year swings in Operating Expenses: crashed 77.74% in 2022 and later skyrocketed 145.85% in 2025.
  • Cresco Labs' Operating Expenses stood at $231.2 million in 2022, then crashed by 70.13% to $69.0 million in 2023, then decreased by 6.41% to $64.6 million in 2024, then skyrocketed by 145.85% to $158.9 million in 2025, then crashed by 59.54% to $64.3 million in 2026.
  • The last three reported values for Operating Expenses were $64.3 million (Q1 2026), $158.9 million (Q4 2025), and $61.5 million (Q3 2025) per Business Quant data.